biostudies-literatureParks TMedical Research CouncilNational Institute for Health Research (NIHR)Public Health England1434-1436https://www.ebi.ac.uk/biostudies/studies/S-EPMC6186853biostudies-literatureUnknown67(9)We evaluated the effect of intravenous immunoglobulin (IVIG) on mortality in clindamycin-treated streptococcal toxic shock syndrome using a meta-analysis. In association with IVIG, mortality fell from 33.7% to 15.7% with remarkable consistency across the single randomized and four nonrandomized studies.Clinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPolyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis.PMC6186853HPRU-2012–10047HPRU-2012-10047G1100449ACF-2016-20-001Norrby-Teglund AWilson CCurtis NParks TSriskandan SfalsePolyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis.We evaluated the effect of intravenous immunoglobulin (IVIG) on mortality in clindamycin-treated streptococcal toxic shock syndrome using a meta-analysis. In association with IVIG, mortality fell from 33.7% to 15.7% with remarkable consistency across the single randomized and four nonrandomized studies.2018-01-01T00:00:00Z2018 Oct2025-04-05T15:44:24.168Z2019-03-27T00:02:44ZS-EPMC61868532978839710.1093/cid/ciy401